Adriana Buskin,Lili Zhu,Valeria Chichagova,Basudha Basu,Sina Mozaffari-Jovin,David Dolan,Alastair Droop,Joseph Collin,Revital Bronstein,Sudeep Mehrotra,Michael Farkas,Gerrit Hilgen,Kathryn White,Dean Hallam,Katarzyna Bialas,Git Chung,Carla Mellough,Yuchun Ding,Natalio Krasnogor,Stefan Przyborski,Jumana Al-Aama,Sameer Alharthi,Yaobo Xu,Gabrielle Wheway,Katarzyna Szymanska,Martin McKibbin,Chris F Inglehearn,David J Elliott,Susan Lindsay,Robin R Ali,David H Steel,Lyle Armstrong,Evelyne Sernagor,Eric Pierce,Reinhard Lüehrmann,Sushma-Nagaraja Grellscheid,Colin A Johnson,Majlinda Lako

Abstract:Summary Mutations in pre-mRNA processing factors (PRPFs) cause 40% of autosomal dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed PRPFs cause retinal disease. To understand the molecular basis of this phenotype, we have generated RP type 11 (PRPF31- mutated) patient-specific retinal organoids and retinal pigment epithelium (RPE) from induced pluripotent stem cells (iPSC). Impaired alternative splicing of genes encoding pre-mRNA splicing proteins occurred in patient-specific retinal cells and Prpf31 +/− mouse retinae, but not fibroblasts and iPSCs, providing mechanistic insights into retinal-specific phenotypes of PRPFs. RPE was the most affected, characterised by loss of apical-basal polarity, reduced trans-epithelial resistance, phagocytic capacity, microvilli, and cilia length and incidence. Disrupted cilia morphology was observed in patient-derived-photoreceptors that displayed progressive features associated with degeneration and cell stress. In situ gene-editing of a pathogenic mutation rescued key structural and functional phenotypes in RPE and photoreceptors, providing proof-of-concept for future therapeutic strategies. eTOC PRPF31 is a ubiquitously expressed pre-mRNA processing factor that when mutated causes autosomal dominant RP. Using a patient-specific iPSC approach, Buskin and Zhu et al. show that retinal-specific defects result from altered splicing of genes involved in the splicing process itself, leading to impaired splicing, loss of RPE polarity and diminished phagocytic ability as well as reduced cilia incidence and length in both photoreceptors and RPE. Highlights Successful generation of iPSC-derived RPE and photoreceptors from four RP type 11 patients RPE cells express the mutant PRPF31 protein and show the lowest expression of wildtype protein PRPF31 mutations result in altered splicing of genes involved in pre-mRNA splicing in RPE and retinal organoids Prpf31 haploinsufficiency results in altered splicing of genes involved in pre-mRNA splicing in mouse retina RPE cells display loss of polarity, reduced barrier function and phagocytosis Photoreceptors display shorter and fewer cilia and degenerative features RPE cells display most abnormalities suggesting they might be the primary site of pathogenesis In situ gene editing corrects the mutation and rescues key phenotypes

Generation of the induced pluripotent stem cell line IOCVi001-A from a patient with the MFRP -related retinitis pigmentosa-nanophthalmos syndrome

Generation of the human iPSC line ESi132-A from a patient with retinitis pigmentosa caused by a mutation in the PRPF31 gene

Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient

Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene

Establishment of Induced Pluripotent Stem Cell Line CSUASOi003- A from an Autosomal Recessive Retinitis Pigmentosa Patient Carrying Compound Heterozygous Mutations in CRB1 Gene

Generation of a Gene-Corrected Human Ipsc Line (Csuasoi004-a-1) from a Retinitis Pigmentosa Patient with Heterozygous C.2699 G>A Mutation in the PRPF6 Gene

Establishment of Non-Integrate Induced Pluripotent Stem Cell Line CSUASOi006-A, from Urine-Derived Cells of a PRPF8-related Dominant Retinitis Pigmentosa Patient

Generation of a gene-corrected isogenic human iPSC line (CSUASOi006-A-1) from a retinitis pigmentosa patient with heterozygous c.5792C > T mutation in the PRPF8 gene

Establishment of Induced Pluripotent Stem Cell Line CSUASOi004-A by Reprogramming Peripheral Blood Mononuclear Cells of a PRPF6-related Dominant Retinitis Pigmentosa Patient.

Gene Correction Reverses Ciliopathy and Photoreceptor Loss in Ipsc-Derived Retinal Organoids from Retinitis Pigmentosa Patients

CRISPR/Cas9-mediated Generation of a Human Induced Pluripotent Stem Cell Line with PRPF6 C.2699 G > A Mutation to Model Retinitis Pigmentosa

Using Inducible Lentiviral Vectors to Generate Induced Pluripotent Stem Cell Line ZOCi001-A from Peripheral Blood Cells of a Patient with CRB1-/- Retinitis Pigmentosa.

An induced pluripotent stem cell line (EHTJUi002-A) derived from a neonate with c.678G > A mutation in the gene <i>FZD4</i> causing exudative vitreoretinopathy

Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation

Modeling PRPF31 retinitis pigmentosa using retinal pigment epithelium and organoids combined with gene augmentation rescue

Generation of an EYS-associated retinitis pigmentosa patient-derived human pluripotent stem cell line (MUi038-A)

Targeted next generation sequencing identified novel mutations in RPGRIP1 associated with both retinitis pigmentosa and Leber's congenital amaurosis in unrelated Chinese patients.

Human iPSC-derived RPE and retinal organoids reveal impaired alternative splicing of genes involved in pre-mRNA splicing in PRPF31 autosomal dominant retinitis pigmentosa

Systematic Evaluation Of A Targeted Gene Capture Sequencing Panel For Molecular Diagnosis Of Retinitis Pigmentosa

Modeling Retinitis Pigmentosa Through Patient-Derived Retinal Organoids

Modeling Retinitis Pigmentosa: Retinal Organoids Generated From the iPSCs of a Patient With the USH2A Mutation Show Early Developmental Abnormalities.